Wolverine Trading, LLC Senseonics Holdings, Inc. Put Options Transaction History

Wolverine Trading, LLC

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$0.32 - $0.49 $32 - $49	100 Added 0.38%	26,500 $9,000
Q2 2024 Aug 14, 2024	BUY	$0.37 - $0.52 $407 - $572	1,100 Added 4.35%	26,400 $10,000
Q1 2024 May 15, 2024	SELL	$0.5 - $0.73 $2,750 - $4,015	-5,500 Reduced 17.86%	25,300 $13,000
Q4 2023 Feb 14, 2024	SELL	$0.48 - $0.7 $96 - $140	-200 Reduced 0.65%	30,800 $17,000
Q3 2023 Nov 15, 2023	BUY	$0.5 - $1.05 $15,500 - $32,550	31,000 New	31,000 $18,000
Q1 2023 May 15, 2023	SELL	$0.68 - $1.25 $71,876 - $132,125	-105,700 Reduced 74.44%	36,300 $25,000
Q4 2022 Feb 14, 2023	SELL	$0.96 - $1.34 $2,400 - $3,350	-2,500 Reduced 1.73%	142,000 $146,000
Q3 2022 Nov 14, 2022	SELL	$1.02 - $2.23 $2,958 - $6,467	-2,900 Reduced 1.97%	144,500 $205,000
Q2 2022 Aug 15, 2022	SELL	$0.94 - $1.94 $16,355 - $33,756	-17,400 Reduced 10.56%	147,400 $149,000
Q1 2022 May 16, 2022	SELL	$1.54 - $3.71 $140,910 - $339,465	-91,500 Reduced 35.7%	164,800 $315,000
Q4 2021 Feb 14, 2022	SELL	$2.58 - $3.91 $165,120 - $250,240	-64,000 Reduced 19.98%	256,300 $705,000
Q3 2021 Nov 12, 2021	BUY	$2.77 - $4.05 $108,307 - $158,355	39,100 Added 13.9%	320,300 $1.05 Million
Q2 2021 Aug 06, 2021	SELL	$1.71 - $4.14 $25,992 - $62,927	-15,200 Reduced 5.13%	281,200 $1.11 Million
Q1 2021 May 14, 2021	BUY	$0.85 - $5.27 $229,245 - $1.42 Million	269,700 Added 1010.11%	296,400 $803,000
Q4 2020 Feb 12, 2021	SELL	$0.36 - $0.95 $3,492 - $9,215	-9,700 Reduced 26.65%	26,700 $24,000
Q1 2019 May 15, 2019	BUY	$2.3 - $3.27 $83,720 - $119,028	36,400 New	36,400 $89,000

137

60M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $526M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.